tiprankstipranks
Trending News
More News >
Advertisement

ABLG - ETF AI Analysis

Compare

Top Page

ABLG

Abacus Fcf International Leaders Etf (ABLG)

Rating:67Neutral
Price Target:
ABLG’s rating suggests it is a solid but not top-tier international equity ETF, supported by strong leaders like TSMC, Novartis, and AstraZeneca, which bring robust financial performance, positive growth outlooks, and exposure to advanced technologies and innovative healthcare. The fund also benefits from quality consumer and industrial names like LVMH and L’Oreal, though some holdings such as Jazz Pharmaceuticals and H World Group face financial or leverage challenges that slightly weigh on the overall assessment. A key risk is the ETF’s meaningful concentration in a few large healthcare and technology names, which can increase volatility if those sectors or companies face setbacks.
Positive Factors
Strong Leading Holdings
Several of the largest positions, especially in technology and health care, have shown strong gains so far this year, helping support the fund’s overall results.
Sector Diversification
The ETF spreads its investments across multiple sectors such as technology, consumer, health care, and industrials, which can help reduce the impact if one industry struggles.
Growing, Mid-Sized Fund
With a moderate level of assets under management, the fund is large enough to be established while still being small enough to remain flexible in its stock selection.
Negative Factors
High U.S. Concentration
Despite its international focus, the fund is heavily tilted toward U.S. exposure, limiting the benefits of global diversification.
Mixed Performance Among Top Holdings
A few of the larger positions have shown weak or negative performance this year, which can drag on the ETF’s overall returns.
Above-Average Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, meaning more of the gross return is lost to fees each year.

ABLG vs. SPDR S&P 500 ETF (SPY)

ABLG Summary

The Abacus Fcf International Leaders ETF (ABLG) invests in leading companies outside the U.S. that generate strong free cash flow, which can be a sign of solid, steady businesses. It does not track a specific index, but follows a theme of owning high-quality international firms across many sectors, with a tilt toward technology, health care, and consumer brands. Well-known holdings include TSMC and Novartis. An investor might choose this ETF for international diversification and long-term growth potential. A key risk is that international stocks and currencies can be volatile, so the value can go up and down significantly over time.
How much will it cost me?The Abacus Fcf International Leaders ETF (ABLG) has an expense ratio of 0.54%, which means you’ll pay $5.40 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on selecting companies with strong free cash flow rather than tracking a broad index.
What would affect this ETF?The Abacus Fcf International Leaders ETF could benefit from global economic growth, particularly in sectors like technology and healthcare, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates or regulatory changes in key international markets, which could impact the profitability of its top holdings like TSMC and Novartis. Additionally, currency fluctuations and geopolitical tensions could negatively affect its global ex-U.S. exposure.

ABLG Top 10 Holdings

ABLG is leaning heavily on international tech and healthcare stars, with chip makers Advantest and TSMC doing much of the heavy lifting as their shares keep rising on the back of AI and advanced semiconductor demand. Big pharma names like Novartis, Roche, and AstraZeneca are also pulling their weight, providing a steadier, defensive backbone. On the consumer side, luxury giant LVMH is losing steam and acting as a mild drag, even as L’Oréal stays more resilient. Overall, it’s a global ex-U.S. play, but clearly tilted toward cash-rich tech and healthcare leaders.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
TSMC4.90%$877.10K$1.58T100.12%
81
Outperform
Advantest4.79%$856.96K$109.24B201.39%
59
Neutral
Novartis4.23%$757.86K$295.46B43.41%
80
Outperform
ASML Holding3.99%$715.22K$529.02B97.15%
81
Outperform
Roche Holding3.70%$661.80K$337.96B22.68%
74
Outperform
Telefonaktiebolaget LM Ericsson3.11%$555.94K$38.16B42.89%
74
Outperform
Jazz Pharmaceuticals2.90%$518.93K$11.42B38.22%
64
Neutral
Rolls-Royce2.86%$512.38K$146.62B72.06%
63
Neutral
H World Group2.80%$502.10K$15.80B41.94%
74
Outperform
Siemens Energy2.78%$497.40K$152.16B183.06%
76
Outperform

ABLG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
32.31
Negative
100DMA
31.79
Negative
200DMA
31.04
Negative
Market Momentum
MACD
-0.36
Positive
RSI
36.68
Neutral
STOCH
24.04
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ABLG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 32.16, equal to the 50-day MA of 32.31, and equal to the 200-day MA of 31.04, indicating a bearish trend. The MACD of -0.36 indicates Positive momentum. The RSI at 36.68 is Neutral, neither overbought nor oversold. The STOCH value of 24.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ABLG.

ABLG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$17.88M0.54%
67
Neutral
$51.13M1.09%
67
Neutral
$30.29M0.90%
63
Neutral
$16.15M0.59%
59
Neutral
$8.84M0.60%
72
Outperform
$5.43M0.55%
60
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ABLG
Abacus Fcf International Leaders Etf
30.42
2.33
8.29%
AADR
AdvisorShares Dorsey Wright ADR ETF
PJIO
PGIM Jennison International Opportunities ETF
ESIM
Eventide International ETF
VNIE
Vontobel International Equity Active ETF
TINS
Templeton International Insights ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement